Literature DB >> 19020260

NSF-active and NSF-inert species of gadolinium: mechanistic and clinical implications.

Phillip H Kuo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19020260     DOI： 10.2214/AJR.08.1179

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  6 in total

Review 1.  Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution.

Authors:  Catherine Do; Joshua DeAguero; Adrian Brearley; Xochitl Trejo; Tamara Howard; G Patricia Escobar; Brent Wagner
Journal:  Kidney360       Date:  2020-06-25

2.  Complications of nephrogenic systemic fibrosis following repeated exposure to gadolinium in a man with hypothyroidism: a case report.

Authors:  Arpita Aggarwal; Allison A Froehlich; Paulina Essah; Nooshin Brinster; Whitney A High; Robert W Downs
Journal:  J Med Case Rep       Date:  2011-12-07

3.  Use of Gadolinium in Individuals with Reduced Kidney Function.

Authors:  Kambiz Kalantari; Sundararaman Swaminathan
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-11       Impact factor: 10.614

4.  Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.

Authors:  Aurang Z Khawaja; Deirdre B Cassidy; Julien Al Shakarchi; Damian G McGrogan; Nicholas G Inston; Robert G Jones
Journal:  Insights Imaging       Date:  2015-08-08

5.  Quantitative estimation of renal function with dynamic contrast-enhanced MRI using a modified two-compartment model.

Authors:  Bin Chen; Yudong Zhang; Xiaojian Song; Xiaoying Wang; Jue Zhang; Jing Fang
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

Review 6.  Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.

Authors:  Julie Davies; Petra Siebenhandl-Wolff; Francois Tranquart; Paul Jones; Paul Evans
Journal:  Arch Toxicol       Date:  2022-01-08       Impact factor: 5.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.